Umeclidinium Brm/Vilanterol Tr
Brand name: Anoro Ellipta
Rank #60 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$294.3M
Total Cost
480,651
Total Claims
$294.3M
Total Cost
14,990
Prescribers
$612
Cost per Claim
56,085
Beneficiaries
615,019
30-Day Fills
$20K
Avg Cost/Provider
32
Avg Claims/Provider
Share of Medicare Part D Spending
0.11%
of total Medicare Part D spending
$294.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $294.3M total
🔎 Data Overview
Average cost of $5,247 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Umeclidinium Brm/Vilanterol Tr
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Chih Chen | Hospitalist | Springfield, MA | 910 | $513K |
| 2 | Bryson Stair | Nurse Practitioner | Columbus, OH | 664 | $351K |
| 3 | Jason Karp | Pulmonary Disease | Lake Success, NY | 339 | $307K |
| 4 | Chitra Kandaswamy | Pulmonary Disease | Fresno, CA | 530 | $291K |
| 5 | Preston Thornhill | Nurse Practitioner | Tifton, GA | 365 | $286K |
| 6 | Steven Geller | Pulmonary Disease | Philadelphia, PA | 501 | $278K |
| 7 | Sidharth Bagga | Internal Medicine | Oroville, CA | 462 | $262K |
| 8 | Andrejs Belovs | Physician Assistant | Lehigh Acres, FL | 239 | $252K |
| 9 | Jessica Moja | Pulmonary Disease | Springfield, IL | 409 | $247K |
| 10 | John Mcardle | Critical Care (Intensivists) | Hartford, CT | 280 | $239K |
| 11 | Jeremiah Reedy | Pulmonary Disease | Springfield, IL | 399 | $237K |
| 12 | Fares Mouchantaf | Pulmonary Disease | Burlington, MA | 417 | $236K |
| 13 | Atul Palkar | Pulmonary Disease | Norwich, CT | 182 | $231K |
| 14 | Naveen Kanathur | Pulmonary Disease | Bettendorf, IA | 424 | $227K |
| 15 | Braden Powers | Pulmonary Disease | Dubuque, IA | 303 | $226K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 57 | Rifaximin (Xifaxan) | $310.0M | 111,328 |
| 58 | Sitagliptin Phos/Metformin Hcl (Janumet) | $302.2M | 329,315 |
| 59 | Tofacitinib Citrate (Xeljanz Xr) | $294.4M | 49,478 |
| 60 | Umeclidinium Brm/Vilanterol Tr (Anoro Ellipta) | $294.3M | 480,651 |
| 61 | Gabapentin (Gabapentin) | $291.0M | 15,142,335 |
| 62 | Cabozantinib S-Malate (Cabometyx) | $287.3M | 11,285 |
| 63 | Rsv Vacc, Pref A And Pref B/Pf (Abrysvo) | $284.5M | 872,396 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology